Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Drug Utilization Patterns and Cost Considerations for Erythropoiesis Stimulating Agents in Cancer Chemotherapy Patients in a Managed Care Setting.

Alyson Mandel, PhD, Richard Weininger, MD, Scott R. McKenzie, MD, Brahim K. Bookhart, MBA, MPH, Catherine T. Piech, MBA

Blood (2007) 110 (11): 5157.

https://doi.org/10.1182/blood.V110.11.5157.5157

Published: 2007

Journal Articles

Trends in Outcomes and Charges of Acute Myeloid Leukemia in the Elderly: A Cross-Sectional Analysis of the Nationwide Inpatient Sample from 1993 to 2001.

Laura M. Katz, MPH, Lee S. Stern, MS, John M. Fastenau, RPh, MPH, Catherine T. Piech, MBA, John J. Doyle, MPH

Blood (2004) 104 (11): 3142.

https://doi.org/10.1182/blood.V104.11.3142.3142

Published: 2004

Journal Articles

Acute Myeloid Leukemia in the Elderly: Longitudinal Outcomes and Hospital Charges in Chemotherapy and Non-Chemotherapy Patients.

Laura M. Katz, MPH, Lee S. Stern, MS, John M. Fastenau, RPh, MPH, Catherine T. Piech, MBA, John J. Doyle, MPH

Blood (2004) 104 (11): 3154.

https://doi.org/10.1182/blood.V104.11.3154.3154

Published: 2004

Journal Articles

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD

Blood (2004) 104 (11): 5306.

https://doi.org/10.1182/blood.V104.11.5306.5306

Published: 2004

Journal Articles

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Susan C. Bolge, PhD, John M. Fastenau, MPH, RPh, Jamie B. Howell, PharmD, MS, Catherine T. Piech, MBA, Jane A. Donohue, PhD

Blood (2004) 104 (11): 5307.

https://doi.org/10.1182/blood.V104.11.5307.5307

Published: 2004

Journal Articles

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

James Rosberg, PhD, MBA, Pierre Y. Cremieux, PhD, Scott R. McKenzie, MD, John M. Fastenau, MPH, RPh, Catherine T. Piech, MBA

Blood (2004) 104 (11): 2216.

https://doi.org/10.1182/blood.V104.11.2216.2216

Published: 2004

NARROW

Drug Utilization Patterns and Cost Considerations for Erythropoiesis Stimulating Agents in Cancer Chemotherapy Patients in a Managed Care Setting.

Trends in Outcomes and Charges of Acute Myeloid Leukemia in the Elderly: A Cross-Sectional Analysis of the Nationwide Inpatient Sample from 1993 to 2001.

Acute Myeloid Leukemia in the Elderly: Longitudinal Outcomes and Hospital Charges in Chemotherapy and Non-Chemotherapy Patients.

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

Email alerts

ASH Publications

American Society of Hematology

Drug Utilization Patterns and Cost Considerations for Erythropoiesis Stimulating Agents in Cancer Chemotherapy Patients in a Managed Care Setting.

Trends in Outcomes and Charges of Acute Myeloid Leukemia in the Elderly: A Cross-Sectional Analysis of the Nationwide Inpatient Sample from 1993 to 2001.

Acute Myeloid Leukemia in the Elderly: Longitudinal Outcomes and Hospital Charges in Chemotherapy and Non-Chemotherapy Patients.

Dosing Patterns of Erythropoietic Agents and Their Association with Provider Visits in Patients with Cancer and Anemia.

Early Results from a Choice Based Conjoint Analysis Assessing Patient Preferences for Selected Features of Erythropoietic Agents.

Benefits of Early Hemoglobin Response to Epoetin Alfa in Elderly Patients with Chemotherapy-Related Anemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only